ArticleLife (Basel, Switzerland)2026
Environmental Exposure to Endocrine-Disrupting Chemicals and SARS-CoV-2 Infection History Among Blood Donors.
Wioletta Ratajczak-Wrona, Katarzyna Bielawska, Jolanta Wrobel, Agnieszka Zebrowska, Kierek Zofia, Magdalena Pabian, Natalia Radziwon, Krzysztof Matuk, Jakub Rudzinski, Wojciech Miltyk and 5 more
Abstract read
In one paragraphArticle in Life (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
15 authors.
Wioletta Ratajczak-WronaDepartment of Immunology, Medical University of Bialystok, 15-269 Bialystok, Poland.ORCID 0000-0002-7634-0875 Katarzyna BielawskaDepartment of Pharmaceutical and Biopharmaceutical Analysis, Faculty of Pharmacy with the Division of Laboratory Medicine, Medical University of Bialystok, 15-089 Bialystok, Poland.ORCID 0000-0003-4028-7352 Jolanta WrobelRegional Centre for Transfusion Medicine, 15-269 Bialystok, Poland.
Kierek ZofiaDepartment of Immunology, Medical University of Bialystok, 15-269 Bialystok, Poland.
Magdalena PabianDepartment of Immunology, Medical University of Bialystok, 15-269 Bialystok, Poland.
Natalia RadziwonDepartment of Immunology, Medical University of Bialystok, 15-269 Bialystok, Poland.
Krzysztof MatukImago Sp. z o.o., 15-688 Bialystok, Poland.
Jakub RudzinskiLaboratory of Environmental Chemoinformatics, Faculty of Chemistry, University of Gdansk, 80-308 Gdansk, Poland.
Wojciech MiltykDepartment of Pharmaceutical and Biopharmaceutical Analysis, Faculty of Pharmacy with the Division of Laboratory Medicine, Medical University of Bialystok, 15-089 Bialystok, Poland.ORCID 0000-0001-5150-6093 Piotr RadziwonRegional Centre for Transfusion Medicine, 15-269 Bialystok, Poland.
Zbigniew WochynskiDepartment of Air Transport Safety, Polish Air Force University, 08-521 Deblin, Poland.ORCID 0000-0003-0935-8490 Funding
Medical University of Białystok no. SUB/1/DN/22/003/2206
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
biomonitoringblood donorschemical mixturesCOVID-19EDCsenvironmental exposureSARS-CoV-2
Identifiers
PMID42653067
PMCPMC13514347
What OpenQuestion holds
Textmetadata
Read underepoch 390